Given the well-established role of NF-κB in regulating inflammatory and fibrotic processes, our findings suggest that targeting this pathway may offer promising therapeutic approaches for preventing or treating COVID-19-associated cardiac fibrosis. Here, NFKB1 is linked to COVID-19.